Related references
Note: Only part of the references are listed.2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Evidence-Based Medical Management of Peripheral Artery Disease
Graham H. Bevan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Vascular Quality of Care Assessment: Clinicians' Adherence to Lipid-Lowering Therapy for Patients with Atherosclerotic Cardiovascular Disease
Joyce Chan et al.
ANNALS OF VASCULAR SURGERY (2020)
Asia-Pacific Consensus Statement on the Management of Peripheral Artery Disease A Report from the Asian Pacific Society of Atherosclerosis and Vascular Disease Asia-Pacific Peripheral Artery Disease Consensus Statement Project Committee
Maria Teresa B. Abola et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2020)
Observational study of the medical management of patients with peripheral artery disease
A. Saratzis et al.
BRITISH JOURNAL OF SURGERY (2019)
Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)
Konstantinos C. Koskinas et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
The progression rate of peripheral arterial disease in patients with intermittent claudication: a systematic review
A. Mizzi et al.
JOURNAL OF FOOT AND ANKLE RESEARCH (2019)
Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis
Peige Song et al.
LANCET GLOBAL HEALTH (2019)
Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature Review
Rupert Bauersachs et al.
CARDIOVASCULAR THERAPEUTICS (2019)
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
Scott M. Grundy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
Victor Aboyans et al.
EUROPEAN HEART JOURNAL (2018)
Statins in Peripheral Artery Disease What Are We Waiting For?
Aaron W. Aday et al.
CIRCULATION (2018)
Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering A Systematic Review and Meta-analysis
Eliano P. Navarese et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
LIPOPROTEIN(A), PCSK9 INHIBITION AND CARDIOVASCULAR RISK: INSIGHTS FROM THE FOURIER TRIAL
M. O'Donoghue et al.
ATHEROSCLEROSIS (2018)
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)
Marc P. Bonaca et al.
CIRCULATION (2018)
Familial Hypercholesterolemia: The Most Frequent Cholesterol Metabolism Disorder Caused Disease
Asier Benito-Vicente et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
G. G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Themes that Determine Quality of Life in Patients with Peripheral Arterial Disease: A Systematic Review
Ahmed Aber et al.
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH (2018)
2017 Taiwan lipid guidelines for high risk patients
Yi-Heng Li et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2017)
Exercise training for intermittent claudication
Mary M. McDermott
JOURNAL OF VASCULAR SURGERY (2017)
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Theo Vos et al.
LANCET (2017)
Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Statins: pros and cons
Iago Pinal-Fernandez et al.
MEDICINA CLINICA (2017)
Efficacy of ezetimibe combined with atorvastatin in the treatment of carotid artery plaque in patients with type 2 diabetes mellitus complicated with coronary heart disease
Jing Wang et al.
INTERNATIONAL ANGIOLOGY (2017)
PCSK9 inhibitors: A new era of lipid lowering therapy
Rahul Chaudhary et al.
WORLD JOURNAL OF CARDIOLOGY (2017)
Interpretation of the evidence for the efficacy and safety of statin therapy
Rory Collins et al.
LANCET (2016)
Familial Hypercholesterolemia-Epidemiology, Diagnosis, and Screening
Siddharth Singh et al.
CURRENT ATHEROSCLEROSIS REPORTS (2015)
A Review of the Pathophysiology and Potential Biomarkers for Peripheral Artery Disease
Smriti Murali Krishna et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Christopher P. Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutation
Hiroshi Mabuchi et al.
ATHEROSCLEROSIS (2014)
The Effect of Lipid Modification on Peripheral Artery Disease after Endovascular Intervention Trial (ELIMIT)
Gerd Brunner et al.
ATHEROSCLEROSIS (2013)
Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans
Michael H. Davidson et al.
ATHEROSCLEROSIS (2013)
Peripheral arterial disease in women
Victoria J. Teodorescu et al.
JOURNAL OF VASCULAR SURGERY (2013)
Improving Compliance with Statins in Patients with Peripheral Arterial Disease: A Quality Improvement Study
Riaz A. Agha et al.
ANNALS OF MEDICINE AND SURGERY (2012)
The effect of ezetimibe on peripheral arterial atherosclerosis depends upon statin use at baseline
Amy M. West et al.
ATHEROSCLEROSIS (2011)
Low-Density Lipoprotein Lowering Does Not Improve Calf Muscle Perfusion, Energetics, or Exercise Performance in Peripheral Arterial Disease
Amy M. West et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Colin Baigent et al.
LANCET (2011)
ACE up the sleeve - are vascular patients medically optimized?
A. P. Coveney et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2011)
Patients with coronary, cerebrovascular or peripheral arterial obstructive disease differ in risk for new vascular events and mortality: the SMART study
Sefanja Achterberg et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2010)
Women and peripheral arterial disease
Ashley K. Vavra et al.
WOMENS HEALTH (2009)
Diagnosis of peripheral arterial disease in general practice: can the ankle-brachial index be measured either by pulse palpation or an automatic blood pressure device?
V. Aboyans et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Simvastatin with or without ezetimibe in familial hypercholesterolemia
John J. P. Kastelein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effectiveness of two statin prescribing strategies with respect to adherence and cardiovascular outcomes: observational study
L. Wei et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Inter-society consensus for the management of peripheral arterial disease (TASC II)
L. Norgren et al.
JOURNAL OF VASCULAR SURGERY (2007)
Smoking and the patency of lower extremity bypass grafts:: A meta-analysis
EM Willigendael et al.
JOURNAL OF VASCULAR SURGERY (2005)
Ezetimibe - A review of its metabolism, pharmacokinetics and drug interactions
T Kosoglou et al.
CLINICAL PHARMACOKINETICS (2005)
Prevalence of and risk factors for peripheral arterial disease in the United States - Results from the National Health and Nutrition Examination Survey, 1999-2000
E Selvin et al.
CIRCULATION (2004)
Knowledge and attitudes regarding cardiovascular disease risk and prevention in patients with coronary or peripheral arterial disease
MM McDermott et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Taking simvastatin in the morning compared with in the evening: randomised controlled trial
A Wallace et al.
BRITISH MEDICAL JOURNAL (2003)
Smoking cessation strategies in patients with peripheral arterial disease: An evidence-based approach
SD Hobbs et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2003)
Classification, epidemiology, risk factors, and natural history of peripheral arterial disease
S Novo
DIABETES OBESITY & METABOLISM (2002)
Outcome events in patients with claudication: A 15-year study in 2777 patients
SC Muluk et al.
JOURNAL OF VASCULAR SURGERY (2001)
Peripheral arterial disease - epidemiological aspects
MH Criqui
VASCULAR MEDICINE (2001)
Share Paper
